Table 5. Medications^ provided, prescribed or recommended for tennis elbow (TE) problems at encounter (April 2000 –March 2015).
| Medication group | Selected generic group^^ | Number of medications | Per 100 TE problems (n = 3,182) (95% CI) |
Percent of TE medications (n = 1,903) (95% CI)^^^ |
|---|---|---|---|---|
| All TE medications | 1,903 | 59.8 (57.4–62.2) | 100.0 (98.3–101.7) | |
| All injected TE medications | 449 | 14.1 (12.7–15.6) | 23.6 (21.3–25.9) | |
| Methylprednisolone | 118 | 3.7 | 6.2 | |
| Betamethasone systemic | 107 | 3.4 | 5.6 | |
| Triamcinolone | 63 | 2.0 | 3.3 | |
| Steroid injection nec | 58 | 1.8 | 3.0 | |
| Lignocaine | 39 | 1.2 | 2.0 | |
| Hydrocortisone systemic | 35 | 1.1 | 1.8 | |
| Local anaesthetic injection | 17 | 0.5 | 0.9 | |
| All topical TE medications | 336 | 10.6 (9.4–11.7) | 17.7 (15.9–19.4) | |
| Diclofenac topical | 250 | 7.9 | 13.1 | |
| Piroxicam topical | 28 | 0.9 | 1.5 | |
| All oral or other TE medications | 1,118 | 35.1 (33.2–37.1) | 58.7 (56.2–61.3) | |
| Diclofenac sodium systemic | 235 | 7.4 | 12.3 | |
| Celecoxib | 138 | 4.3 | 7.3 | |
| Meloxicam | 138 | 4.3 | 7.3 | |
| Ibuprofen | 136 | 4.3 | 7.1 | |
| Paracetamol | 95 | 3.0 | 5.0 | |
| Paracetamol/Codeine | 58 | 1.8 | 3.0 | |
| Rofecoxib | 55 | 1.7 | 2.9 | |
| Naproxen | 53 | 1.7 | 2.8 | |
| Diclofenac potassium | 47 | 1.5 | 2.5 | |
| Piroxicam oral | 22 | 0.7 | 1.2 | |
| NSAIDs | 21 | 0.7 | 1.1 |
^ As classified in Coding Atlas of Pharmaceutical Substances (CAPS).
^^ Includes all CAPS generic groups whose rate was at least 0.5 per 100 TE problems; sum is less than subtotals of medication groups.
^^^ 1903 medications in total, associated with 1659 TE problems. The 95% CI analysis considers all 3182 problems, either with (n = 1659, 52.1%) or without (n = 1523, 47.9%) associated medication.
nec: not elsewhere classified.